Median overall survival for platinum-resistant ovarian cancer typically ranges from nine to 15 months after the diagnosis of resistance. Credit: Marko Aliaksandr / Shutterstock.com
Unlock FREE Access to Premium Content
Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends.
With a free Pharmaceutical Technology profile, you can:
Access exclusive analyst commentary and expert insights
View premium forecasts and data-driven pharmaceutical industry insights
Stay up to date with pharma news, manufacturing innovation, and regulatory developments
Receive alerts when new premium content is published